Mobile Menu

Cyclopharm Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: CYC

What does Cyclopharm Limited do?

Cyclopharm is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2023 the company generated total revenue of $32,389,000 including sales and other revenue. In 2023 Cyclopharm had 87 employees including employees from all subsidiaries under the company's control.

The Chief Executive of Cyclopharm is Mr James Steven Mcbrayer whose official title is MANAGING DIRECTOR & CHIEF EXECUTIVE OFFICER. The Chairman of Cyclopharm is Mr David Heaney whose official title is Independent Non-Executive Chairman.

Cyclopharm Limited - Products & Brands

Cyclopharm Limited is a radiopharmaceutical business that provides equipment and products specialising in lung health. The company's main product is Technegas, a functional lung imaging product. Cyclopharm also has a joint venture with Alfred Health Solutions and Macquarie University Hospital called Macquarie Medical Imaging. Cyclopharm has a nuclear medicine product, Ultralute, pending market authorisation.

Cyclopharm Limited - Key Personnel

To view Cyclopharm Limited's full key personnel, see purchase options.

Cyclopharm Limited - Financial Statements

Cyclopharm Limited Financial Profit & Loss Account

BALANCE DATE 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Sales Revenue 26,339.0 22,878.0 17,312.0 14,523.0 14,079.0
Other Revenue
Total Revenue
Cost of Goods Sold
Depreciation
R & D Expenditure
To view all financial data for Cyclopharm Limited, see purchase options.

Cyclopharm Limited's Competitive Environment

Cyclopharm Limited operates in the following industries:

Cyclopharm Limited's main competitors:

To view all of Cyclopharm Limited's operating industries and competitors, see purchase options.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Cyclopharm Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Cyclopharm Limited by position type and title.

Enterprise Financials

Get a full view of Cyclopharm Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Cyclopharm Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Cyclopharm Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Cyclopharm Limited operates in.

Competitor Benchmarking

Compare Cyclopharm Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Cyclopharm Limited.

Subsidiaries

View a list of Cyclopharm Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Cyclopharm Limited, including founding information, past announcements, mergers and major projects.

Why buy this enterprise profile on Cyclopharm Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on BHP Group Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Purchase to read full report

100% Money Back Guarantee Digicert Trusted
Download Sample Report

Included in Report

  • Enterprise History & Synopsis Enterprise History & Synopsis
  • Enterprise Financial Statements Enterprise Financial Statements
  • Financial Ratios Financial Ratios
  • Industry Averages Industry Averages
  • Competitive Landscape Competitive Landscape
  • Key Enterprise Personnel Key Enterprise Personnel
  • Subsidiaries & Ownership Structure Subsidiaries & Ownership Structure

View Top 2,000 Companies

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal